Russell Frank Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $50.6M | Buy |
757,235
+86,420
| +13% | +$5.77M | 0.09% | 249 |
|
|
2015
Q4 | $45.3M | Buy |
670,815
+75,403
| +13% | +$5.09M | 0.08% | 275 |
|
|
2015
Q3 | $31.8M | Buy |
595,412
+72,010
| +14% | +$3.85M | 0.06% | 362 |
|
|
2015
Q2 | $32.9M | Sell |
523,402
-73,890
| -12% | -$4.65M | 0.05% | 405 |
|
|
2015
Q1 | $28.7M | Buy |
597,292
+54,107
| +10% | +$2.6M | 0.05% | 409 |
|
|
2014
Q4 | $17.7M | Buy |
543,185
+38,947
| +8% | +$1.27M | 0.03% | 622 |
|
|
2014
Q3 | $14.8M | Buy |
504,238
+152,163
| +43% | +$4.46M | 0.03% | 696 |
|
|
2014
Q2 | $10.8M | Buy |
352,075
+51,009
| +17% | +$1.57M | 0.02% | 870 |
|
|
2014
Q1 | $12.6M | Buy |
301,066
+25,143
| +9% | +$1.06M | 0.02% | 754 |
|
|
2013
Q4 | $10.4M | Buy |
275,923
+172,974
| +168% | +$6.51M | 0.02% | 838 |
|
|
2013
Q3 | $2.78M | Sell |
102,949
-16,040
| -13% | -$433K | ﹤0.01% | 1682 |
|
|
2013
Q2 | $2.78M | Buy |
+118,989
| New | +$2.78M | 0.01% | 1581 |
|